145 related articles for article (PubMed ID: 32721475)
1. MicroRNAs as regulators of VEGFA and NFE2L2 in cancer.
Cuzziol CI; Castanhole-Nunes MMU; Pavarino ÉC; Goloni-Bertollo EM
Gene; 2020 Oct; 759():144994. PubMed ID: 32721475
[TBL] [Abstract][Full Text] [Related]
2.
Stuchi LP; Castanhole-Nunes MMU; Maniezzo-Stuchi N; Biselli-Chicote PM; Henrique T; Padovani Neto JA; de-Santi Neto D; Girol AP; Pavarino EC; Goloni-Bertollo EM
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32824922
[TBL] [Abstract][Full Text] [Related]
3. Regulation of
Cuzziol CI; Marzochi LL; Possebon VS; Kawasaki-Oyama RS; Mattos MF; Junior VS; Ferreira LAM; Pavarino ÉC; Castanhole-Nunes MMU; Goloni-Bertollo EM
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806488
[TBL] [Abstract][Full Text] [Related]
4. miR-155 overexpression is followed by downregulation of its target gene, NFE2L2, and altered pattern of VEGFA expression in the liver of melanoma B16-bearing mice at the premetastatic stage.
Aksenenko MB; Palkina NV; Sergeeva ON; Yu Sergeeva E; Kirichenko AK; Ruksha TG
Int J Exp Pathol; 2019 Oct; 100(5-6):311-319. PubMed ID: 32043657
[TBL] [Abstract][Full Text] [Related]
5.
Akdemir B; Nakajima Y; Inazawa J; Inoue J
Mol Cancer Res; 2017 Nov; 15(11):1570-1578. PubMed ID: 28760781
[TBL] [Abstract][Full Text] [Related]
6. Understanding the role of NRF2-regulated miRNAs in human malignancies.
Shah NM; Rushworth SA; Murray MY; Bowles KM; MacEwan DJ
Oncotarget; 2013 Aug; 4(8):1130-42. PubMed ID: 24029073
[TBL] [Abstract][Full Text] [Related]
7. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
Sun X; Zuo H; Liu C; Yang Y
Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
[TBL] [Abstract][Full Text] [Related]
9. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors.
Yamamoto S; Inoue J; Kawano T; Kozaki K; Omura K; Inazawa J
Mol Cancer Res; 2014 Jan; 12(1):58-68. PubMed ID: 24307696
[TBL] [Abstract][Full Text] [Related]
10. NFE2L2/NRF2 Activity Is Linked to Mitochondria and AMP-Activated Protein Kinase Signaling in Cancers Through miR-181c/Mitochondria-Encoded Cytochrome c Oxidase Regulation.
Jung KA; Lee S; Kwak MK
Antioxid Redox Signal; 2017 Nov; 27(13):945-961. PubMed ID: 28383996
[TBL] [Abstract][Full Text] [Related]
11. The Dual Roles of NRF2 in Cancer.
Menegon S; Columbano A; Giordano S
Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
Cheng X; Ku CH; Siow RC
Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
[TBL] [Abstract][Full Text] [Related]
13. Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells.
Liu M; Hu C; Xu Q; Chen L; Ma K; Xu N; Zhu H
Biosci Rep; 2015 Sep; 35(5):. PubMed ID: 26341629
[TBL] [Abstract][Full Text] [Related]
14. The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma.
Kanitz A; Imig J; Dziunycz PJ; Primorac A; Galgano A; Hofbauer GF; Gerber AP; Detmar M
PLoS One; 2012; 7(11):e49568. PubMed ID: 23166713
[TBL] [Abstract][Full Text] [Related]
15. Disruption of microRNA nuclear transport in human cancer.
Melo SA; Esteller M
Semin Cancer Biol; 2014 Aug; 27():46-51. PubMed ID: 24607282
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor erythroid 2-like 2 (Nrf2) expression in end-stage liver disease.
Kurzawski M; Dziedziejko V; Urasińska E; Post M; Wójcicki M; Miętkiewski J; Droździk M
Environ Toxicol Pharmacol; 2012 Jul; 34(1):87-95. PubMed ID: 22459801
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs: novel regulators in the hallmarks of human cancer.
Ruan K; Fang X; Ouyang G
Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
[TBL] [Abstract][Full Text] [Related]
18. Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population.
Siedlinski M; Postma DS; Boer JM; van der Steege G; Schouten JP; Smit HA; Boezen HM
Respir Res; 2009 Aug; 10(1):73. PubMed ID: 19671143
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells.
Narasimhan M; Patel D; Vedpathak D; Rathinam M; Henderson G; Mahimainathan L
PLoS One; 2012; 7(12):e51111. PubMed ID: 23236440
[TBL] [Abstract][Full Text] [Related]
20. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2.
Chen X; Zeng K; Xu M; Liu X; Hu X; Xu T; He B; Pan Y; Sun H; Wang S
Cell Death Dis; 2019 Feb; 10(2):131. PubMed ID: 30755600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
